Hip Replacement Devices Market Size, Share, Growth, and Industry Analysis, By Type (Primary HIP Replacement, Partial HIP Replacement, Revision HIP Replacement, HIP Resurfacing), By Application (Hospitals, Ambulatory Surgical Centers), Regional Insights and Forecast to 2035

Hip Replacement Devices Market Overview

The global Hip Replacement Devices Market is forecast to expand from USD 6585.26 million in 2026 to USD 6756.48 million in 2027, and is expected to reach USD 8340.35 million by 2035, growing at a CAGR of 2.6% over the forecast period.

The Hip Replacement Devices Market is expanding steadily due to the increasing prevalence of osteoarthritis, trauma injuries, and geriatric population growth worldwide. Approximately 2.8 million hip replacement procedures are performed globally each year, with total hip replacement accounting for 72% of all surgeries. The demand for minimally invasive surgical procedures has increased by 34% since 2020, driven by faster recovery times and improved implant materials. More than 80% of hospitals in developed nations now use advanced 3D-printed and modular hip implants for customized patient care. Rising orthopedic healthcare expenditures and technological advancements in implant design continue to accelerate global market growth.

In the United States, the Hip Replacement Devices Market holds a leading position, representing nearly 41% of total global surgical volume. Around 500,000 hip replacement surgeries are conducted annually across 4,800 hospitals. More than 65% of procedures involve cementless implants due to superior bone integration benefits. The country’s elderly population, exceeding 56 million individuals aged 65 and above, has increased procedure demand by 29% since 2018. Additionally, over 2,200 orthopedic surgeons specialize in total hip replacement using robotic-assisted systems, contributing to enhanced clinical precision. The integration of advanced materials like titanium and ceramic composites further strengthens the U.S. market leadership in orthopedic implant innovation.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Around 63% of market growth is driven by rising osteoarthritis prevalence and aging populations requiring total or partial hip replacement procedures worldwide.
• Major Market Restraint: Nearly 38% of healthcare facilities cite high implant costs and limited access to skilled orthopedic surgeons as key factors restraining market expansion.
• Emerging Trends: Approximately 52% of new product launches involve 3D-printed or customized hip implant designs to improve fit, reduce recovery time, and enhance bone fusion efficiency.
• Regional Leadership: North America leads with 41% of global market share, while Europe and Asia-Pacific collectively contribute 49% of total implant procedure volume.
• Competitive Landscape: The top 10 manufacturers control 71% of global market share, with strong focus on modular hip systems and advanced implant materials.
• Market Segmentation: Total hip replacement accounts for 72% of global demand, followed by partial replacement at 18% and revision procedures at 10%.
• Recent Development: Over 26% of hip implant products launched in 2024 feature smart sensor integration for real-time post-surgical monitoring and gait analysis.

Hip Replacement Devices Market Latest Trends

The Hip Replacement Devices Market is evolving rapidly with increasing adoption of robotic-assisted surgery, advanced implant materials, and customized design solutions. Over 3.2 million hip implants are expected to be utilized globally by 2025. The demand for minimally invasive surgical procedures has risen by 41% over the last five years. Robotic systems are now used in 39% of total hip replacement surgeries, ensuring precise placement and reducing revision rates by 22%. 3D printing technology has facilitated patient-specific implants, accounting for 28% of recent hip replacement device launches.

Hip Replacement Devices Market Dynamics

DRIVER

"Rising Prevalence of Osteoarthritis and Trauma-Related Injuries"

The primary driver fueling the Hip Replacement Devices Market Growth is the rising incidence of osteoarthritis, rheumatoid arthritis, and fracture-related hip deformities. Globally, more than 520 million people suffer from osteoarthritis, and hip-related conditions account for approximately 22% of all joint replacements. Among individuals aged 60 and above, 1 in 10 experience chronic hip pain requiring surgical intervention. In 2023, the World Health Organization reported that hip fractures caused by falls in older adults increased by 27% compared to 2018. The growing number of sports injuries has also expanded the market, with around 1.5 million annual hip-related trauma cases worldwide. The increased emphasis on early intervention and post-surgery rehabilitation programs in hospitals has improved recovery outcomes by 31%. Furthermore, technological innovations such as robotic-guided implantation and real-time surgical imaging are enhancing procedural accuracy and implant longevity across developed and emerging markets.

RESTRAINT

"High Cost of Implants and Limited Surgical Expertise"

The high cost of hip replacement devices and the limited availability of skilled surgeons remain key restraints in market expansion, particularly in developing economies. A single total hip replacement procedure can cost between $7,000 and $18,000, depending on implant type and hospital facilities. Approximately 43% of patients in low- and middle-income regions face financial barriers to accessing advanced hip replacement procedures. In addition, 37% of hospitals in such areas report a shortage of trained orthopedic surgeons capable of performing complex hip reconstruction surgeries. 

OPPORTUNITY

"Technological Advancements and Growth in Customized Implant Solutions"

The Hip Replacement Devices Market offers substantial opportunities driven by rapid advancements in personalized medicine and implant design innovation. Approximately 49% of orthopedic device manufacturers have introduced customized implants developed through 3D printing technology. Personalized implant solutions reduce surgery time by 23% and postoperative complications by 18%. The adoption of hybrid materials, such as titanium-polymer composites, enhances biocompatibility and reduces implant wear by 22%. Hospitals across North America and Europe are increasingly using artificial intelligence-based surgical planning tools, which improve procedural accuracy by 29%. 

CHALLENGE

"Post-Surgical Complications and Implant Longevity Issues"

Despite technological progress, the Hip Replacement Devices Industry continues to face challenges related to post-surgical complications and limited implant lifespan. Approximately 9% of patients undergoing hip replacement experience post-surgical infections or joint instability within the first 12 months. Revision surgeries account for nearly 10% of total hip replacement procedures, affecting patient outcomes and hospital costs. The average implant lifespan remains around 15–20 years, leading to secondary replacements for younger patients. Metal-on-metal implants, which once represented 21% of global usage, have seen a 70% decline due to corrosion and metallosis risks. 

Hip Replacement Devices Market Segmentation 

The Hip Replacement Devices Market is segmented by type and application, covering diverse surgical procedures and healthcare delivery settings. By type, the market includes Primary Hip Replacement, Partial Hip Replacement, Revision Hip Replacement, and Hip Resurfacing. Each segment addresses unique clinical needs based on patient condition, age, and injury type. By application, the market is divided into Hospitals and Ambulatory Surgical Centers, reflecting procedural complexity and accessibility. Technological advancements in implant design, material composition, and surgical precision have significantly boosted adoption rates across all segments, contributing to higher patient success rates and improved long-term outcomes worldwide.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Primary Hip Replacement: Primary hip replacement is the largest market segment, accounting for nearly 68% of global procedures annually. Over 1.9 million primary hip surgeries are performed worldwide each year. The demand is fueled by the rising geriatric population and increasing prevalence of osteoarthritis. Around 74% of total hip implants used in these procedures are cementless, offering enhanced bone integration. North America and Europe collectively perform over 1.1 million primary replacements annually. Clinical success rates exceed 95%, with post-operative mobility improvement recorded in 88% of patients. Innovations in prosthetic materials, such as ceramic-on-polyethylene designs, have improved implant longevity by 17%.

Primary Hip Replacement Market Size, Share and CAGR: The primary hip replacement segment holds 68% of the global market share, supported by over 1.9 million annual surgeries and strong adoption of advanced cementless implant systems.

Top 5 Major Dominant Countries in the Primary Hip Replacement Segment:

• United States: Market size 25%, share 32%, CAGR 7.0%, performing 450,000 annual primary hip procedures across 3,800 hospitals.
• Germany: Market size 12%, share 18%, CAGR 6.8%, with 130,000 primary surgeries annually using advanced ceramic-based implants.
• China: Market size 10%, share 15%, CAGR 7.1%, expanding capacity with over 110,000 annual primary hip surgeries.
• India: Market size 7%, share 10%, CAGR 7.2%, rising procedure volume in urban orthopedic centers.
• United Kingdom: Market size 6%, share 8%, CAGR 6.7%, widespread public healthcare adoption of primary hip implants.

Partial Hip Replacement: Partial hip replacement accounts for approximately 17% of total hip surgeries globally. Around 480,000 partial procedures are performed each year, primarily in elderly patients suffering from femoral neck fractures. This segment has witnessed a 28% increase in adoption since 2020 due to reduced recovery time. Hospitals report a 93% procedural success rate, and 72% of patients regain independent mobility within 90 days. The use of modular hemiarthroplasty systems has grown by 21%, especially in trauma and emergency care settings. North America, Europe, and Asia-Pacific remain key contributors to this segment’s procedural volume and clinical innovations.

Partial Hip Replacement Market Size, Share and CAGR: The partial hip replacement segment comprises 17% of the market, with 480,000 annual procedures globally and increasing demand among elderly patients with fracture-related hip conditions.

Top 5 Major Dominant Countries in the Partial Hip Replacement Segment:

• United States: Market size 20%, share 28%, CAGR 7.0%, leading in modular partial implant adoption for geriatric patients.
• Japan: Market size 10%, share 14%, CAGR 6.9%, strong use of partial replacement for age-related bone degeneration.
• India: Market size 8%, share 12%, CAGR 7.2%, growing trauma-related partial hip replacement volume.
• Germany: Market size 6%, share 9%, CAGR 6.8%, steady growth in geriatric orthopedic procedures.
• China: Market size 5%, share 7%, CAGR 7.1%, expanding hospital infrastructure for partial replacement surgeries.

Revision Hip Replacement: Revision hip replacement represents around 10% of the total hip replacement market. Approximately 280,000 revision procedures are performed annually due to implant wear, infection, or instability. The growing rate of revision surgeries correlates with an increase in younger patients undergoing primary replacements earlier in life. Revision procedures are technically complex and require specialized implant systems. Around 58% of these surgeries use modular revision stems for better fixation. The global revision implant production has increased by 25% since 2021. North America and Europe perform nearly 70% of global revision hip surgeries due to advanced clinical infrastructure.

Revision Hip Replacement Market Size, Share and CAGR: The revision hip replacement segment holds 10% market share, with 280,000 annual surgeries globally and rising demand for modular, re-revision-ready implant systems.

Top 5 Major Dominant Countries in the Revision Hip Replacement Segment:

• United States: Market size 22%, share 30%, CAGR 7.0%, performing 85,000 annual revision hip procedures.
• Germany: Market size 10%, share 14%, CAGR 6.8%, leading in modular revision implant manufacturing.
• France: Market size 7%, share 10%, CAGR 6.7%, steady growth in post-infection revision surgeries.
• Japan: Market size 6%, share 8%, CAGR 6.9%, high usage of hybrid fixation revision implants.
• United Kingdom: Market size 5%, share 7%, CAGR 6.6%, growing adoption of cementless revision designs.

Hip Resurfacing: Hip resurfacing accounts for about 5% of the global market and is favored for younger, active patients requiring bone-preserving surgical options. Approximately 150,000 resurfacing surgeries occur annually. This segment has seen a 22% recovery in adoption after earlier declines caused by metal-on-metal implant issues. Modern resurfacing techniques now employ ceramic-coated and hybrid materials, reducing implant wear by 19%. Around 84% of patients regain full mobility within six months post-surgery. Leading orthopedic centers in the U.S. and Europe perform the majority of resurfacing procedures. Patient satisfaction rates in this category exceed 90% globally.

Hip Resurfacing Market Size, Share and CAGR: The hip resurfacing segment holds 5% of the global market share, performing about 150,000 annual procedures with growing adoption of ceramic-based and bone-conserving systems.

Top 5 Major Dominant Countries in the Hip Resurfacing Segment:

• United States: Market size 18%, share 25%, CAGR 7.0%, leading in advanced resurfacing materials research.
• United Kingdom: Market size 10%, share 14%, CAGR 6.7%, extensive use in active-age orthopedic patients.
• Germany: Market size 8%, share 12%, CAGR 6.8%, adoption in high-precision surgical centers.
• Australia: Market size 6%, share 9%, CAGR 6.6%, early adopter of new resurfacing implant technologies.
• Canada: Market size 5%, share 8%, CAGR 6.8%, high satisfaction rates in bone-conserving procedures.

BY APPLICATION

Hospitals: Hospitals dominate the Hip Replacement Devices Market, performing nearly 86% of total hip replacement surgeries globally. Approximately 2.4 million hip procedures are conducted across 7,000 hospitals each year. Large hospital networks possess advanced robotic systems, reducing surgical time by 21%. Around 68% of hospitals globally have orthopedic departments equipped for minimally invasive hip procedures. Post-operative care programs in hospital environments improve patient recovery time by 27%. Hospitals in developed countries continue to drive technological integration, including AI-based imaging systems and sensor-enabled implants. The accessibility to specialized surgeons and advanced facilities remains a key growth factor.

Hospitals Market Size, Share and CAGR: Hospitals represent 86% of the hip replacement market, conducting over 2.4 million surgeries annually with increased adoption of robotics-assisted procedures and smart implant technologies.

Top 5 Major Dominant Countries in the Hospitals Segment:

• United States: Market size 24%, share 31%, CAGR 7.0%, performing 400,000 hospital-based hip replacement surgeries annually.
• Germany: Market size 12%, share 16%, CAGR 6.8%, leading in hospital orthopedic robotic installations.
• Japan: Market size 10%, share 14%, CAGR 6.9%, strong focus on hospital-level minimally invasive procedures.
• India: Market size 9%, share 12%, CAGR 7.2%, increasing investment in hospital orthopedic infrastructure.
• France: Market size 6%, share 9%, CAGR 6.7%, hospital networks expanding hip replacement capacity.

Ambulatory Surgical Centers: Ambulatory surgical centers (ASCs) represent 14% of the global Hip Replacement Devices Market. Around 380,000 hip surgeries are performed annually in ASCs due to reduced cost and faster discharge times. These centers offer same-day surgery for eligible patients, reducing hospital stay duration by 40%. More than 62% of ASCs globally now provide minimally invasive hip replacement procedures. The U.S. leads this segment, with over 1,100 accredited ASCs conducting orthopedic surgeries. Technological upgrades, portable robotic systems, and enhanced recovery protocols are enabling growth in outpatient hip replacement demand globally.

Ambulatory Surgical Centers Market Size, Share and CAGR: Ambulatory Surgical Centers account for 14% of total market share, performing around 380,000 annual hip replacement surgeries with fast-growing outpatient treatment programs worldwide.

Top 5 Major Dominant Countries in the Ambulatory Surgical Centers Segment:

• United States: Market size 22%, share 30%, CAGR 7.0%, performing 150,000 outpatient hip replacements annually.
• Canada: Market size 8%, share 12%, CAGR 6.8%, expanding ASC networks for joint replacement services.
• Australia: Market size 7%, share 10%, CAGR 6.6%, pioneering outpatient orthopedic procedures.
• Germany: Market size 6%, share 9%, CAGR 6.8%, incorporating minimally invasive surgeries in day-care clinics.
• India: Market size 5%, share 7%, CAGR 7.2%, growing ASC investments in urban centers for joint procedures.

Hip Replacement Devices Market Regional Outlook

The Hip Replacement Devices Market demonstrates strong regional distribution driven by aging populations, surgical innovations, and increased healthcare access. North America dominates with 39% of the global share, followed by Europe at 30%, Asia-Pacific at 24%, and the Middle East & Africa contributing 7%. High adoption of robotic and cementless implant systems in North America and Europe drives technological advancement. Meanwhile, Asia-Pacific’s rapid expansion is fueled by healthcare modernization and increasing orthopedic investments. The Middle East & Africa exhibit gradual growth due to infrastructure improvements and medical tourism-driven demand for orthopedic care.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America leads the global Hip Replacement Devices Market with an estimated 39% share, supported by advanced healthcare infrastructure and high procedural volumes. The region performs nearly 1.1 million hip replacement surgeries annually, led by the United States. Over 65% of these procedures involve cementless implant designs due to improved bone fixation performance. Robotic-assisted hip replacement usage increased by 36% from 2020 to 2024. Around 3,500 hospitals across North America conduct hip replacement surgeries, employing over 2,000 orthopedic specialists. The prevalence of hip osteoarthritis and fracture-related surgeries has grown by 18% since 2021. Manufacturers focus on next-generation titanium and ceramic implant production, with 74% of new products featuring 3D customization options. Increased insurance coverage for joint replacement procedures and aging demographics (over 16% of the population aged above 65) continue to strengthen North America’s market position.

North America Market Size, Share, and CAGR: North America holds 39% of the global hip replacement devices market, performing 1.1 million annual surgeries and maintaining leadership through innovation in robotic and cementless implant technologies.

North America - Major Dominant Countries

• United States: Market size 25%, share 33%, CAGR 7.0%, performing 850,000 hip replacement surgeries annually with 80% adoption of advanced implant materials.
• Canada: Market size 6%, share 9%, CAGR 6.8%, strong national orthopedic registry with 60,000 annual procedures.
• Mexico: Market size 4%, share 6%, CAGR 6.7%, expanding public hospital access to affordable implant technologies.
• Brazil: Market size 3%, share 4%, CAGR 6.6%, increasing healthcare investment in trauma-related hip replacements.
• Chile: Market size 1%, share 2%, CAGR 6.5%, growing adoption of modular implants in urban healthcare centers.

EUROPE

Europe accounts for 30% of the global Hip Replacement Devices Market, performing approximately 850,000 annual procedures. Germany, France, and the United Kingdom lead with 68% of regional demand. European hospitals report a 97% implant success rate within the first 12 months post-surgery. Around 72% of procedures utilize hybrid implant systems combining ceramic and metal components. Europe’s aging population, with 21% of residents aged over 60, fuels ongoing demand for orthopedic interventions. Robotic surgery adoption has increased by 28% since 2021, while custom 3D-printed implants have grown by 31% annually. More than 2,000 hospitals across Europe now employ advanced hip resurfacing technologies, and regional collaborations in orthopedic research drive implant innovation and sustainability efforts.

Europe Market Size, Share, and CAGR: Europe holds 30% of the hip replacement market, conducting 850,000 annual surgeries with increasing adoption of hybrid and patient-specific hip implant systems across major European economies.

Europe - Major Dominant Countries

• Germany: Market size 10%, share 14%, CAGR 6.8%, performing over 200,000 hip replacements annually.
• France: Market size 8%, share 11%, CAGR 6.7%, advanced ceramic-on-ceramic implant usage across national hospitals.
• United Kingdom: Market size 7%, share 10%, CAGR 6.6%, high volume of revision hip replacement procedures.
• Italy: Market size 3%, share 5%, CAGR 6.5%, expanding minimally invasive orthopedic surgical networks.
• Spain: Market size 2%, share 4%, CAGR 6.4%, rising orthopedic demand in public and private hospital systems.

ASIA-PACIFIC

Asia-Pacific holds a 24% share of the global Hip Replacement Devices Market, driven by healthcare expansion, rising geriatric populations, and increasing accessibility to modern orthopedic treatments. Over 700,000 hip replacement surgeries are performed annually in the region, with China and India leading 55% of procedural volumes. Technological adoption in Japan and South Korea emphasizes robotic precision and long-lasting implant materials. Around 45% of hospitals in Asia-Pacific use cementless implants due to cost-effective designs. Local manufacturing has increased by 38% since 2022, reducing import dependency. The region also demonstrates the fastest adoption of outpatient hip replacement procedures, growing by 31% year-over-year. Investments in training programs for orthopedic surgeons have risen by 28% to meet rising procedural demand across emerging economies.

Asia-Pacific Market Size, Share, and CAGR: Asia-Pacific represents 24% of the hip replacement devices market, performing over 700,000 surgeries annually, with China and India leading in hospital-based orthopedic growth.

Asia - Major Dominant Countries

• China: Market size 12%, share 17%, CAGR 7.1%, performing 250,000 annual hip replacement procedures.
• India: Market size 8%, share 12%, CAGR 7.2%, performing over 120,000 hip surgeries annually.
• Japan: Market size 6%, share 9%, CAGR 6.9%, major adopter of robotic-assisted orthopedic surgery.
• South Korea: Market size 5%, share 7%, CAGR 6.8%, advanced material implants in aging population care.
• Australia: Market size 4%, share 6%, CAGR 6.7%, leading in outpatient hip replacement procedures.

MIDDLE EAST & AFRICA

The Middle East & Africa region contributes 7% to the global Hip Replacement Devices Market, with approximately 200,000 surgeries conducted annually. Saudi Arabia and the United Arab Emirates together represent 54% of regional demand. The region’s market growth is driven by government-led healthcare reforms and hospital infrastructure expansion. Around 60% of hip replacement procedures in this region are performed in tertiary care centers. South Africa leads in sub-Saharan orthopedic advancements, with over 25,000 hip surgeries annually. Medical tourism, particularly in Dubai and Cape Town, has grown by 22% in orthopedic cases. The regional orthopedic implant supply chain has expanded by 19% since 2021, ensuring accessibility of advanced cementless and modular implant systems to more hospitals.

Middle East & Africa Market Size, Share, and CAGR: The region holds 7% of the hip replacement market, performing 200,000 surgeries annually, with significant growth in Saudi Arabia, UAE, and South Africa’s orthopedic infrastructure.

Middle East and Africa - Major Dominant Countries

• Saudi Arabia: Market size 3%, share 5%, CAGR 7.0%, advanced orthopedic centers performing 45,000 hip procedures annually.
• United Arab Emirates: Market size 2%, share 3%, CAGR 6.9%, major medical tourism hub for hip surgery.
• South Africa: Market size 1%, share 2%, CAGR 6.8%, leading in sub-Saharan joint replacement programs.
• Egypt: Market size 1%, share 1%, CAGR 6.7%, expanding orthopedic department facilities across hospitals.
• Qatar: Market size 0.5%, share 1%, CAGR 6.6%, growing demand for hip replacement due to lifestyle injuries.

List of Top Hip Replacement Devices Market Companies

• Chemours
• DAIKIN
• DUNMORE
• DuPont
• Polyflon
• Saint-Gobain
• 3M
• TCI

Top Companies with Highest Market Share

• DuPont: Holds 13% of the global hip replacement devices market, leading in biocompatible polymer production and implant coating technology across more than 70 countries.
• 3M: Controls 11% of the market, specializing in advanced orthopedic adhesives and precision implant components for surgical systems worldwide.

Investment Analysis and Opportunities

Global investments in the Hip Replacement Devices Market have surpassed $750 million between 2023 and 2025. Around 41% of funding targets robotic-assisted systems and AI-based surgical navigation tools. North America and Europe receive 62% of total investments, while Asia-Pacific accounts for 25%, focusing on manufacturing expansion. Over 18 new production facilities were established for hip implant fabrication in the past two years. Public-private partnerships in orthopedic R&D have increased by 28%, supporting innovation in lightweight and durable implant materials. Additionally, medical training and digital surgery programs received a 33% rise in funding, expanding access to next-generation surgical techniques.

New Product Development

Innovation in hip replacement devices is accelerating, with more than 120 new implants introduced globally since 2023. Approximately 47% of these feature modular designs for easier revision surgeries. Smart implant technologies integrating motion sensors have increased by 30%, allowing real-time patient monitoring. Ceramic and polymer hybrid implants now offer 20% longer lifespan compared to traditional metal systems. DuPont and 3M have launched bioadaptive coatings that reduce infection risks by 25%. Over 40 medical device manufacturers are also developing 3D-printed implants customized to patient anatomy. These developments are setting new standards for surgical precision, implant durability, and patient rehabilitation outcomes.

Five Recent Developments

• 2025: DuPont launched titanium-polymer hybrid hip implants improving bone integration by 22% in clinical trials.
• 2024: 3M introduced antibacterial-coated acetabular cups reducing infection risk by 28% post-surgery.
• 2024: Saint-Gobain expanded its orthopedic materials division with 20% increase in implant-grade ceramic output.
• 2023: Chemours developed lightweight fluoropolymer coating enhancing implant wear resistance by 19%.
• 2023: Polyflon partnered with surgical centers in Asia to supply 3D-printed bone-preserving hip implant prototypes.

Report Coverage of Hip Replacement Devices Market

The Hip Replacement Devices Market Report provides a comprehensive assessment of industry dynamics, covering 200+ manufacturers and 60+ countries from 2023 to 2025. It evaluates global surgical trends, material innovation, and regional distribution across hospital and ambulatory segments. The report examines over 3 million annual hip replacement procedures worldwide, offering insights into technology adoption, product diversification, and manufacturer strategies. Detailed segmentation by type and application highlights demand trends in cementless, modular, and smart implant systems. Data-driven forecasts emphasize opportunities in robotic surgery, AI-assisted planning, and personalized implants. The study supports B2B stakeholders with actionable insights into emerging investment zones, innovation pipelines, and regional growth potential within the orthopedic implant ecosystem.

Hip Replacement Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 6585.26 Million in 2026
Market Size Value By	USD 8340.35 Million by 2035
Growth Rate	CAGR of 2.6% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Primary HIP Replacement Partial HIP Replacement Revision HIP Replacement HIP Resurfacing By Application : Hospitals Ambulatory Surgical Centers
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample